Hematological Malignancy
Showing 1 - 25 of 2,432
Oral Complications in Hematological Malignancies
Not yet recruiting
- Hematologic Malignancy
-
Assiut, EgyptAssiut university
Mar 6, 2023
Hematological Malignancy, Neutropenia Trial in Morgantown (Eravacycline)
Not yet recruiting
- Hematological Malignancy
- Neutropenia
-
Morgantown, West VirginiaAaron Cumpston
Sep 12, 2022
Tumor, Plasma Cell, Lymphoma Trial in Toulouse (Comprehensive Geriatric Assessment)
Recruiting
- Neoplasm, Plasma Cell
- Lymphoma
- Comprehensive Geriatric Assessment
-
Toulouse, FranceUniversity Hospital Toulouse
Oct 12, 2022
Participants Previously Treated With Century Therapeutics
Not yet recruiting
- Hematological Malignancy
- Solid Tumor Malignancy
- No Intervention
- (no location specified)
Mar 3, 2023
Hematologic Malignancy Trial in Copenhagen (HM-PRO)
Active, not recruiting
- Hematologic Malignancy
- HM-PRO
-
Copenhagen, DenmarkDept. of Hematology
Jun 14, 2022
Hematological Malignancy, Solid Tumor Trial (OT-A201, IMids, Bevacizumab)
Not yet recruiting
- Hematological Malignancy
- Solid Tumor
- OT-A201
- +4 more
- (no location specified)
Apr 24, 2023
CD7+ Acute Leukemia, CD7+ Lymphoma Trial in Hangzhou (anti-CD7 CAR-T)
Recruiting
- CD7+ Acute Leukemia
- CD7+ Lymphoma
- anti-CD7 CAR-T
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital,College of Medicine, Zhejiang Univ
Sep 18, 2022
Haematological Malignancy Trial in Nice (6 sessions of adapted physical activity after stem cell transplant)
Recruiting
- Haematological Malignancy
- 6 sessions of adapted physical activity after stem cell transplant
-
Nice, FranceCHU NICE, hopital ARCHET 1, hématologie
Jun 13, 2022
Membrane Target Detection for Leukemia Treatment
Recruiting
- Hematological Malignancy
- Study sample collection
-
Columbia, MissouriUniversity of Missouri
Dec 29, 2021
Solid Tumor, Hematological Malignancy Trial in Fairfax (Locus Health iPhone App)
Not yet recruiting
- Solid Tumor
- Hematological Malignancy
- Locus Health iPhone App
-
Fairfax, VirginiaInova Schar Cancer Institute
Oct 24, 2023
Bone Marrow Disease, Hematological Malignancy Trial in Kayseri (Musictherapy)
Active, not recruiting
- Bone Marrow Disease
- Hematological Malignancy
- Musictherapy
-
Kayseri, TurkeyKayseri City Hospital
Jun 8, 2023
Hematological Malignancy, Cancer-Related Anemia Trial in Wuhan (Shengxuening Tablet, Ferrous succinate)
Recruiting
- Hematological Malignancy
- Cancer-Related Anemia
- Shengxuening Tablet
- Ferrous succinate
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Mar 13, 2023
The Optimization of Haploidentical Hematopoietic Stem Cell
Not yet recruiting
- Hematological Malignancy
- ATG
- Post-transplantation cyclophosphamide
-
Beijing, Beijing, ChinaPeople's Hospital of Peking University
Nov 28, 2022
Hematological Malignancy, COVID-19 Trial in Beijing (Anti-COVID-19 Antibody SA55 for Injection)
Recruiting
- Hematological Malignancy
- COVID-19
- Anti-COVID-19 Antibody SA55 for Injection
-
Beijing, Beijing, ChinaBeijing Boren Hospital
Jan 9, 2023
Hematological Malignancy Trial in Ningbo (Etoposide, Cytarabine, PEG-rhG-CSF)
Recruiting
- Hematological Malignancy
- Etoposide
- +2 more
-
Ningbo, Zhejiang, ChinaThe Affiliated People's Hospital of Ningbo University.
Aug 18, 2022
Hematological Malignancy Trial (Thymoglobulin Injectable Product)
Not yet recruiting
- Hematological Malignancy
- Thymoglobulin Injectable Product
- (no location specified)
Sep 27, 2023
Hematological Malignancy Trial in Houston (Fludarabine Phosphate, Cyclophosphamide, CAR.5/IL15-transduced CB-NK cells)
Not yet recruiting
- Hematological Malignancy
- Fludarabine Phosphate
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Solid Tumor, Hematological Malignancy Trial in Australia (ATG-017)
Recruiting
- Solid Tumor
- Hematological Malignancy
-
East Melbourne, Victoria, Australia
- +4 more
Jan 11, 2023
Hematological Malignancy Trial in Roskilde (Taste-test, Standard care)
Enrolling by invitation
- Hematological Malignancy
- Taste-test
- Standard care
-
Roskilde, DenmarkDepartment of Hematology
May 5, 2022
Hematological Malignancy, Lymphoma Trial in Canton (SG2501)
Recruiting
- Hematological Malignancy
- Lymphoma
-
Canton, OhioGabrail Cancer Center Research, LLC
Aug 3, 2022
CXCR4, PET/CT, Hematological Malignancy Trial in Wuhan (68Ga-pentixafor, PET/CT)
Not yet recruiting
- CXCR4
- +2 more
- 68Ga-pentixafor
- PET/CT
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Feb 15, 2022
Hematologic Malignancy Trial in Tianjin (BR108 injection)
Recruiting
- Hematologic Malignancy
- BR108 injection
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
Aug 25, 2023
GVHD, Chronic, Hematological Malignancy Trial in Copenhagen (Lee Symptom Scala)
Active, not recruiting
- GVHD, Chronic
- Hematological Malignancy
- Lee Symptom Scala
-
Copenhagen, DenmarkRigshospitalet
Jul 14, 2022
Hematological Malignancy, Leukemia, Multiple Myeloma Trial in Milwaukee (Evomela, Fludarabine, Total Body Irradiation)
Recruiting
- Hematological Malignancy
- Multiple Myeloma
- Evomela
- +2 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Oct 4, 2022
Following Treatment With Fate Therapeutics' Engineered Cellular
Terminated
- Hematological Malignancy
- Genetically engineered NK cells
-
Phoenix, Arizona
- +4 more
Aug 24, 2022